Company news

VolitionRX Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

VolitionRx Limited Schedules Second Quarter 2025 Earnings Conference Call and Business Update

August 8, 2025

VolitionRx Announces Pricing of $1.2 Million Registered Direct Offering

August 4, 2025

Nu.Q® Discover Expands Global Adoption and Epigenetic Innovation

July 16, 2025

Volition Announces Groundbreaking Lateral Flow Test for Point-of-Care Quantification of Nucleosomes

July 8, 2025

Volition Announces MARS Consortium Clinical Study Suggests Nu.Q® H3.1. Concentrations are Closely Associated with Sepsis and Organ Failure

June 12, 2025

Volition Announces Two Oral Presentations at Asian Meeting of Animal Medicine Specialties

June 4, 2025

VolitionRx Limited Announces Successful Detection of Nucleosomes in Cats

May 19, 2025

VolitionRx Limited Announces First Quarter 2025 Financial Results and Business Update

May 15, 2025

VolitionRx Limited Schedules First Quarter 2025 Earnings Conference Call and Business Update

May 12, 2025

VolitionRX Limited: Outlines broad strategy to become the 'NETs company' worldwide through licensing and updates progress of Nu.Q® NETs test adoption

May 7, 2025

VolitionRX Limited: Revolutionizing the diagnosis and monitoring of life-altering diseases for both humans and animals in multi-billion dollar markets

April 29, 2025

← Newer news releases

Calls

The 5 newest of 24 calls. Every call is listed under its year.

Decks

The 5 newest of 29 decks. Every deck is listed under its year.